Single Dose Crossover Comparative Bioavailability Study of Bupropion Hcl MR Tablet 300mg

NCT05160090 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Bupropion HCl MR tablets 300mg

Sponsor

Alembic Pharmaceuticals Ltd.